{'fraction_non_alphanumeric': 0.028790786948176585, 'fraction_numerical': 0.0, 'mean_word_length': 5.779220779220779, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical trial cytology: Use of on‐site evaluation of small biopsy and FNA samples for clinical trials and biomarker research studies

After increased requests for biopsies for clinical trials and biomarker research, the University of Pittsburgh Medical Center created a clinical trial research service that partnered pathology, radiology, and medicine to facilitate rapid on‐site evaluation (ROSE) of fine‐needle aspiration (FNA) and/or core needle biopsy (CNB) samples to confirm the presence of tumor in these studies.